Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Medifast Inc (MED)

Medifast Inc (MED)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 117,270
  • Shares Outstanding, K 11,032
  • Annual Sales, $ 385,790 K
  • Annual Income, $ -18,670 K
  • EBIT $ -14 M
  • EBITDA $ -1 M
  • 60-Month Beta 0.53
  • Price/Sales 0.29
  • Price/Cash Flow 24.24
  • Price/Book 0.56

Options Overview Details

View History
  • Implied Volatility 54.55% (-2.70%)
  • Historical Volatility 39.97%
  • IV Percentile 65%
  • IV Rank 16.81%
  • IV High 176.01% on 03/26/26
  • IV Low 30.01% on 03/16/26
  • Expected Move (DTE 3) 0.57 (5.32%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 320
  • Volume Avg (30-Day) 444
  • Put/Call OI Ratio 0.04
  • Today's Open Interest 25,150
  • Open Int (30-Day) 29,017
  • Expected Range 10.14 to 11.28

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate $-0.55
  • Number of Estimates 1
  • High Estimate $-0.55
  • Low Estimate $-0.55
  • Prior Year $-0.11
  • Growth Rate Est. (year over year) -400.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
9.45 +13.33%
on 03/25/26
10.85 -1.29%
on 04/14/26
+1.09 (+11.33%)
since 03/13/26
3-Month
9.22 +16.16%
on 03/13/26
12.14 -11.78%
on 01/26/26
-0.97 (-8.30%)
since 01/14/26
52-Week
9.22 +16.16%
on 03/13/26
15.46 -30.72%
on 07/10/25
-2.21 (-17.11%)
since 04/14/25

Most Recent Stories

More News
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Medifast, Inc. (NYSE: MED)

NEW YORK , April 14, 2026 /PRNewswire/ -- Purcell & Lefkowitz LLP announces that it is investigating Medifast, Inc. (NYSE: MED) on behalf of the company's shareholders.  The investigation seeks...

MED : 10.76 (+1.22%)
3 Consumer Stocks That Concern Us

3 Consumer Stocks That Concern Us

POST : 100.72 (+0.86%)
USNA : 18.46 (+1.60%)
MED : 10.76 (+1.22%)
3 of Wall Street’s Favorite Stocks We Steer Clear Of

3 of Wall Street’s Favorite Stocks We Steer Clear Of

AIZ : 222.74 (+0.15%)
SHAK : 102.30 (+1.64%)
MED : 10.76 (+1.22%)
3 Reasons MED is Risky and 1 Stock to Buy Instead

3 Reasons MED is Risky and 1 Stock to Buy Instead

MED : 10.76 (+1.22%)
1 Small-Cap Stock with Exciting Potential and 2 We Find Risky

1 Small-Cap Stock with Exciting Potential and 2 We Find Risky

LMB : 86.59 (+1.07%)
ROG : 117.32 (-1.45%)
MED : 10.76 (+1.22%)
Winners And Losers Of Q4: Medifast (NYSE:MED) Vs The Rest Of The Personal Care Stocks

Winners And Losers Of Q4: Medifast (NYSE:MED) Vs The Rest Of The Personal Care Stocks

MED : 10.76 (+1.22%)
Medifast Announces Cooperation Agreement with Steamboat Capital

Company Agrees to Nominate Parsa Kiai and Jeff Rose as Director Candidates at 2026 Annual Meeting of Stockholders

MED : 10.76 (+1.22%)
3 Out-of-Favor Stocks with Open Questions

3 Out-of-Favor Stocks with Open Questions

PZZA : 34.89 (-0.34%)
OLED : 97.89 (-2.62%)
MED : 10.76 (+1.22%)
Medifast’s Q4 Earnings Call: Our Top 5 Analyst Questions

Medifast’s Q4 Earnings Call: Our Top 5 Analyst Questions

MED : 10.76 (+1.22%)
Scientific Evidence Demonstrates OPTAVIA®’s Metabolic Health Benefits, Opening the Door to Qualified HSA/FSA Clients

As part of its continued focus on improving metabolic health, Medifast ® (NYSE: MED) today announced that OPTA VIA ’s comprehensive metabolic...

MED : 10.76 (+1.22%)

Business Summary

Medifast is a leading manufacturer and distributor of clinically-proven healthy living products and programs. The company produces, distributes and sells weight loss, weight management and healthy living products throughits direct online channels as well as franchise weight control centers. The company...

See More

Key Turning Points

3rd Resistance Point 11.50
2nd Resistance Point 11.07
1st Resistance Point 10.85
Last Price 10.76
1st Support Level 10.20
2nd Support Level 9.77
3rd Support Level 9.55

See More

52-Week High 15.46
Fibonacci 61.8% 13.08
Fibonacci 50% 12.34
Fibonacci 38.2% 11.60
Last Price 10.76
52-Week Low 9.22

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.